Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 6 of 18
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
NCT05618912
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
NCT05611307
Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type 1 Diabetes
NCT05577169
Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.
NCT05519150
Coronary Collaterals and Post-reperfusion Intramyocardial Hemorrhage
NCT05898425
Renal Considerations in the Heat Stress Recommendations (Aim2)
NCT05458843
Negative Pressure Wound Therapy-PICO: Cosmesis in Repeat C-Sections
NCT05266053
Efficacy of COMET on Prolific Participants
NCT05379881
Digital Detection of Dementia (D Cubed) Studies: D2
NCT05231954
Low-intensity Stepped Care for Internalizing Distress
NCT05441111
AutoMated BUrn Diagnostic System for Healthcare (AMBUSH)
NCT05167461
Serial Testing To Assess Cognitive Function In Cancer
NCT06160700
Impact of EUS Guided Treatment of Gastric Varices
NCT05521685
Neural Basis of Sensory and Motor Learning: Functional Connections
NCT05124301
Academic-Community EPINET (AC-EPINET)
NCT04497857
Comparison of Tissue Oxygenation Measurement Using Multimodal Devices
NCT05784103
Use of Aromatherapy to Reduce Symptom Burden
NCT05251337
Nutritional Regulation of Leukocyte Function
NCT05191758
Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis
NCT05227300
Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB)
NCT06336681
ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery
NCT05257941
The Effect of Intermittent Fasting on Acute Subconcussive Head Impacts
NCT05236127
Does Oxytocin Alter Tolerance to or Motivation for Alcohol
NCT05312008
Gluteal Squeeze for Left Colon Distension
NCT04827485
Menopause Racing Heart Study
NCT05062057
Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study
NCT04616612
PRIMA Intervention for Adults With Mild Cognitive Impairment and Their Caregivers
NCT04515875
HIV-related Insomnia and Inflammation
NCT04721067
Coconut Oil vs. Commercial Ultrasound Gel In Obstetric Ultrasounds
NCT05653362
Mirabegron and Physiological Function in Cold Environments
NCT04766021
Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study
NCT05165108
Systematic Pediatric Assessment of Rome Criteria (SPARC)
NCT04773158
Limb Health and Socket Pressure in Response to Powered Ankle Protheses
NCT05112679
Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder
NCT04884763
The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals
NCT05100459
Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration
NCT04971681
Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets
NCT04199624
Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members
NCT03966807
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
NCT04520698
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
NCT04675788
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors
NCT05364450
A Theory Driven, Rurally Tailored, Family-Based, Telehealth Intervention for Childhood Obesity
NCT04720703
Healthy Volunteer Short Chain Fatty Acid Study
NCT05254340
Effect of Perioperative Gabapentin on Postoperative Opioid Requirements
NCT05494385
The Effects of the Safe and Sound Protocol on PTSD Symptoms and Anxiety
NCT04999852
Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study
NCT05033743
Sedline EEG Guided Depth of Anesthesia
NCT05051982
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)
NCT04930055
Electroceutical Dressing Technology (EDT) Against Wound Microbial Biofilm Infection
NCT04794621
HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy
NCT04798014
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.